Single-cell atlas of diverse immune populations in the advanced biliary tract cancer microenvironment

Immunotherapies have been explored in treating solid tumors, albeit with disparate clinical effects in distinct cancer types. Systematic interrogation of immune cells in the tumor microenvironment (TME) is vital to the prediction of immunotherapy response and the development of innovative immunotherapeutics. To comprehensively characterize the immune microenvironment in advanced biliary tract cancer (BTC), we utilized single-cell RNA sequencing in unselected viable cells from 16 matched samples, and identified nineteen cell subsets from a total of 45,851 cells, in which exhausted CD8(+) T cells, macrophages, and dendritic cells (DCs) in BTC were shown to augment and communicate within the TME. Transcriptional profiles coupled with T cell receptor (TCR) sequences revealed that exhausted CD8(+) T cells retained clonal expansion and high proliferation in the TME, and some of them highly expressed the endoplasmic reticulum stress (ER) response gene, XBP1, indicating the role of ER stress in remodeling TME. Functional assays demonstrated that XBP1 and common immune checkpoints (PD1, TIGIT) were significantly upregulated in CD8(+) T cells cocultured within the TME of BTC cells (GBC-SD, HCCC-9810). When treating the coculture groups with the specific inhibitor of IRE1 alpha-XBP1 (4 mu 8C), the downregulation of TIGIT was observed in the treatment group. Collectively, comprehensive transcriptome profiling provides deep insights into the immune atlas in advanced BTC, which might be instrumental in exploring innovative immunotherapy strategies.

Automated summary

The study utilized single-cell RNA sequencing to comprehensively analyze the immune microenvironment in advanced biliary tract cancer (BTC) and identified multiple subsets of immune cells. The results showed that exhausted CD8(+) T cells, macrophages, and dendritic cells played important roles in augmenting and communicating within the tumor microenvironment. Additionally, the study revealed the involvement of XBP1 and immune checkpoint TIGIT in the remodeling of the tumor microenvironment.